AYTU BIOPHARMA, INC. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↑+5.0% +$6M
$122M
Current Assets
$76M
Cash & Equivalents↑+47.2% +$10M
$30M
ST Investments
—
Receivables↑+21.7% +$6M
$31M
Inventory↓-21.9% -$2M
$9M
Net PPE↓-6.2% -$32K
$484K
Goodwill
—
Intangibles↓-12.8% -$6M
$44M
Total Liabilities
—
Current Liabilities↑+2.4% +$2M
$66M
Account Payables↑+21.9% +$3M
$14M
Long-Term Debt↑+0.2% +$15K
$10M
Short-Term Debt
$4M
Stockholders Equity↓-53.8% -$17M
$14M
Retained Earnings↓-7.7% -$24M
$-342M
Operating Lease ROU Asset↓-18.6% -$219K
$959K
Operating Lease Liability↓-9.1% -$117K
$1M
Finance Lease ROU Asset
$0
Gross PP&E↑+7.3% +$85K
$1M
Accumulated Depreciation↑+18.0% +$117K
$768K
Inventory Raw Materials↑+144.9% +$716K
$1M
Inventory WIP↓-41.5% -$1M
$2M
Inventory Finished Goods↓-24.8% -$2M
$6M
Debt Due Y1↑+0.0% +$0
$2M
Debt Due Y2↑+0.0% +$0
$2M
Debt Due Y3↑+0.0% +$0
$7M
Debt Due Y4↑+0.0% +$0
$7M
Total Debt Carrying Amount↑+0.0% +$0
$12M
Contract Asset
—
Contract Liability
—
Contract Liability (Current)
—